博卡病毒感染是儿童肝损伤的潜在触发因素
Bera Enes Seyrek1, Kubra Aykac2, İncinur Saltık Temizel3
1Hacettepe University School of Medicine, Ankara, Türkiye.
Journal of viral hepatitis
|February 20, 2025
概括
人类博卡病毒 (HBoV) 可能会导致儿童的肝脏问题,甚至导致严重的结果,如肝衰竭. 需要进一步的研究来证实这种联系,并指导儿童HBoV感染的治疗.
科学领域:
- 儿科胃肠病学和肝病学
- 病毒学和传染病学.
背景情况:
- 人类博卡病毒 (HBoV) 是一种新兴的病毒病原体.
- HBoV主要与儿童的呼吸道和胃肠道感染有关.
- 儿童肝功能障碍中HBoV的作用尚未得到充分证实.
研究的目的:
- 调查人类博卡病毒感染与儿童肝脏功能障碍之间的潜在关联.
- 描述患有HBoV和肝酶升高或急性肝衰竭的儿科病例的临床表现和结果.
主要方法:
- 六名儿科患者的回顾性病例系列分析.
- 临床数据审查,包括肝功能测试,病毒检测和并发感染.
- 记录患者的结果,包括肝移植的需要和死亡率.
主要成果:
- 在HBoV感染期间,六例儿科病例呈现肝酶升高或急性肝衰竭.
- 观察到的严重结局包括肝移植和一次死亡.
- 与其他病原体的同时感染很常见,使临床管理复杂化.
结论:
- 人类博卡病毒感染可能与儿童的严重肝损伤有关.
- 虽然没有证实直接因果关系,但研究结果表明HBoV是儿童肝功能障碍的潜在贡献者.
- 需要进一步的研究来阐明HBoV相关的肝损伤的机制和临床影响.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Bacterial Gastroenteritis
Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...


